Press Releases

May 04, 2021
BOSTON --(BUSINESS WIRE)--May 4, 2021-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management is scheduled to
Mar 11, 2021
BOSTON --(BUSINESS WIRE)--Mar. 11, 2021-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will
Jan 07, 2021
BOSTON --(BUSINESS WIRE)--Jan. 7, 2021-- Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that Andrew Miller , Ph.D., chief
Displaying 11 - 20 of 21
Top